Opinion piece: The hunt for a new TB vaccine: Why we are now so close, and why it matters.
Associate Professor Angelique Kany Kany Luabeya has written an opinion piece for the Spotlight in which she highlights that the world’s only tuberculosis vaccine, BCG is more than a century old and offers limited protection for children. She describes how South African researchers are now leading pivotal clinical trials for three promising new TB vaccine candidates—suggesting that a long‑awaited breakthrough may finally be within reach.
